Bilcare Limited (NSE:BI)
India · Delayed Price · Currency is INR 74.29
+1.19 (1.63%)
At close: Nov 9, 2026
Bilcare Market Cap
Bilcare has a market cap or net worth of 1.83 billion as of November 10, 2026. Its market cap has decreased by 22.60% in one year.
Market Cap
1.83B
Enterprise Value
7.19B
Revenue
8.43B
Global Rank
n/a
Country Rank
n/a
PE Ratio
6.15
ChartMarket Cap Chart
Since December 17, 2003, Bilcare's market cap has increased from 1.11B to 1.83B, an increase of 64.93%. That is a compound annual growth rate of 2.21%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 9, 2026 | 1.83B | -2.50% |
| Dec 31, 2025 | 1.88B | 21.50% |
| Dec 31, 2024 | 1.54B | -17.03% |
| Dec 29, 2023 | 1.86B | 107.97% |
| Dec 30, 2022 | 894.72M | -54.38% |
| Dec 31, 2021 | 1.96B | 91.27% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Accretion Pharmaceuticals | 2.26B |
| Gennex Laboratories | 2.18B |
| Sanjivani Paranteral | 2.14B |
| Kerala Ayurveda | 1.97B |
| Coral Laboratories | 1.91B |
| Bio Medica Laboratories | 1.86B |
| Oxygenta Pharmaceutical | 1.85B |
| Bilcare | 1.83B |